116 related articles for article (PubMed ID: 2792350)
1. [Role of the collateral coronary circulation in the mechanism of action of verapamil and diltiazem on the ischemic myocardium].
Kirsanova GIu; Tsorin IB; Chichkanov GG
Farmakol Toksikol; 1989; 52(3):33-7. PubMed ID: 2792350
[TBL] [Abstract][Full Text] [Related]
2. [Underlying mechanism of favorable effect of Ca++-antagonists on conduction delay observed in ischemic myocardium (author's transl)].
Nakaya H
Hokkaido Igaku Zasshi; 1981 May; 56(3):335-45. PubMed ID: 7319455
[TBL] [Abstract][Full Text] [Related]
3. [The anti-ischemic properties of verapamil and its effect on myocardial functional potentials in coronary artery occlusion].
Paperno AA; Kovalev GV; Gurbanov KG
Farmakol Toksikol; 1991; 54(2):26-8. PubMed ID: 1884790
[TBL] [Abstract][Full Text] [Related]
4. [Characteristics of the action of different doses of panangin and isoptin on the collateral blood supply to the heart in coronarogenic myocardial lesion].
Trifonov SA; Sapozhkov AV
Farmakol Toksikol; 1982; 45(6):41-5. PubMed ID: 7151998
[TBL] [Abstract][Full Text] [Related]
5. Verapamil in two reperfusion models of myocardial infarction. Temporary protection of severely ischemic myocardium without limitation of ultimate infarct size.
Reimer KA; Jennings RB
Lab Invest; 1984 Dec; 51(6):655-66. PubMed ID: 6503220
[TBL] [Abstract][Full Text] [Related]
6. Effects of diltiazem on experimental myocardial ischemia and on left ventricular performance.
Clozel JP; Théroux P; Bourassa MG
Circ Res; 1983 Feb; 52(2 Pt 2):I120-8. PubMed ID: 6831646
[TBL] [Abstract][Full Text] [Related]
7. Myocardial perfusion distal to an acute or chronic coronary artery occlusion: effects of diltiazem and nifedipine.
Zyvoloski MG; Brooks HL; Gross GJ; Warltier DC
J Pharmacol Exp Ther; 1982 Aug; 222(2):494-500. PubMed ID: 7097568
[TBL] [Abstract][Full Text] [Related]
8. [Mechanisms of verapamil prevention of disorders of cardiac contractile function during ischemia and reperfusion].
Bratus' VV; Bezus'ko AG; Shabaran SS; Filonenko VV
Patol Fiziol Eksp Ter; 1989; (5):26-9. PubMed ID: 2616210
[TBL] [Abstract][Full Text] [Related]
9. [Collateral coronary blood circulation and its role in the mechanism of the anti-ischemic (antianginal) action of pharmacologic preparations].
Chichkanov GG; Tsorin IB
Farmakol Toksikol; 1989; 52(2):15-24. PubMed ID: 2663540
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two dihydropyridine calcium antagonists on coronary collateral blood flow in acute myocardial ischemia.
Jolly SR; Hardman HF; Gross GJ
J Pharmacol Exp Ther; 1981 Apr; 217(1):20-5. PubMed ID: 7205654
[TBL] [Abstract][Full Text] [Related]
11. [Effect of dopamine on the blood supply and oxygen balance of the ischemic myocardium].
Katkov EV; Sapozhkov AV
Farmakol Toksikol; 1988; 51(4):41-4. PubMed ID: 3191971
[TBL] [Abstract][Full Text] [Related]
12. Effect of diltiazem on myocardial blood flow.
Bache RJ; Dymek DJ
Circulation; 1982 Jan; 65(1 Pt 2):I19-26. PubMed ID: 7053295
[TBL] [Abstract][Full Text] [Related]
13. [Effect of nialamide on collateral circulation in the myocardium during acute occlusion of the coronary artery].
Sapozhkov AV
Farmakol Toksikol; 1972; 35(2):190-3. PubMed ID: 5021653
[No Abstract] [Full Text] [Related]
14. Effects of diltiazem on vulnerability to atrial and ventricular reentrant arrhythmias in the normal and ischemic heart.
Heuer H; Gülker H; Thale J; Meyer M; Weiss U; Bendeer F
Arzneimittelforschung; 1983; 33(8):1113-6. PubMed ID: 6685488
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of ischemic heart disease in the elderly. Comparison of diltiazem, verapamil and gallopamil].
Simonelli P; Papa A; Macciocchi B; Auriemma F; Vetrano A; Scaletta Romeo di Santillo M; Ceriello A
Minerva Cardioangiol; 1993 May; 41(5):193-204. PubMed ID: 8355859
[TBL] [Abstract][Full Text] [Related]
16. [Effect of Krebs cycle intermediates on the blood supply and energy metabolism of ischemic myocardium].
Baĭramkulov KhD; Gatsura VV
Biull Eksp Biol Med; 1978 Sep; 86(9):317-9. PubMed ID: 698378
[TBL] [Abstract][Full Text] [Related]
17. [The protective action of vasocyclin (prostacyclin) on the ischemic myocardium].
Kazanova GV; Tsorin IB; Chirkova EIu; Chichkanov GG
Farmakol Toksikol; 1991; 54(3):24-7. PubMed ID: 1915814
[TBL] [Abstract][Full Text] [Related]
18. [Changes in contractility parameters, coronary flow and myocardial oxygen consumption following intravenous diltiazem in patients with coronary heart disease].
Oeff M; Schröder R; Biamino G
Z Kardiol; 1984 Nov; 73(11):717-23. PubMed ID: 6523970
[TBL] [Abstract][Full Text] [Related]
19. Studies on mechanisms of diltiazem-induced protection of the ischemic myocardium: selective myocardial depressant action of diltiazem on an ischemic isolated blood-perfused canine papillary muscle preparation.
Ngai JH; Yabuuchi Y; Schwartz A; Millard RW
J Pharmacol Exp Ther; 1983 May; 225(2):462-9. PubMed ID: 6842404
[TBL] [Abstract][Full Text] [Related]
20. [The effect of dopamine on the systemic hemodynamic indices, on the blood supply of an ischemic focus and on the plasma enzyme activity in dogs with acute coronary occlusion].
Katkov EV; Sysoliatina NA
Farmakol Toksikol; 1989; 52(5):19-23. PubMed ID: 2599071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
